Viewing nowCombinationSevicar HCT Tablets 10/40/12.5 mg
Olmesartan Medoxomil 40mg · Amlodipine Besylate 13.888mg +1 more
Tablet · Prescription medication · Combination
Daicel Corporation (Co., Ltd.)

MFDS item code 201206780 · Approved 2012.09.13 · Insurance code 680900090
Treatment of essential hypertension not controlled with amlodipine and olmesartan in combination
Combination therapy with Amlodipine and Olmesartan Medoxomil is used for patients whose blood pressure is not properly controlled due to essential hypertension. These medications help lower blood pressure and reduce cardiovascular risk. The two components work together to dilate blood vessels and effectively control blood pressure, making it a useful treatment option for hypertension management.
Take 1 tablet once daily with water, with or without food. If possible, it is recommended to take the medicine at the same time each day (e.g., in the morning). Before starting this medicine, it is recommended that the dose be adjusted using the individual components (olmesartan medoxomil and amlodipine as monotherapy or combination therapy). However, if blood pressure is not controlled with combination therapy with amlodipine and olmesartan medoxomil, switching directly to this medicine may be considered as follows. The maximum dose of this medicine is 10/40/25mg of amlodipine/olmesartan medoxomil/hydrochlorothiazide. Since the maximum blood pressure-lowering effect occurs within 2 weeks after administration, adjust the dose at intervals of at least 2 weeks, taking the patient's blood pressure response into account. The recommended doses are as follows. 5/20/12.5mg: For patients whose blood pressure is not adequately controlled with combination therapy of amlodipine/olmesartan medoxomil 5/20mg. 5/40/12.5mg: For patients whose blood pressure is not adequately controlled with combination therapy of amlodipine/olmesartan medoxomil 5/40mg or with this medicine 5/20/12.5mg. 5/40/25mg: For patients whose blood pressure is not adequately controlled with this medicine 5/40/12.5mg. 10/40/12.5mg: For patients whose blood pressure is not adequately controlled with combination therapy of amlodipine/olmesartan medoxomil 10/40mg or with this medicine 5/40/12.5mg. 10/40/25mg: For patients whose blood pressure is not adequately controlled with this medicine 5/40/25mg or this medicine 10/40/12.5mg. (The content of each component is listed in the order amlodipine/olmesartan medoxomil/hydrochlorothiazide.) 5/20/0mg → 5/20/12.5mg 5/40/0mg → 5/40/12.5mg → 5/40/25mg 10/40/0mg → 10/40/12.5mg → 10/40/25mg The maximum dose of this medicine for patients with mild or moderate renal impairment (creatinine clearance 30-60mL/min) is 20/5/12.5 milligrams once daily. Monitoring of potassium and creatinine levels is recommended in patients with moderate renal impairment. This medicine must not be administered to patients with severe renal impairment (creatinine clearance < 30mL/min). Use caution when administering to patients with mild or moderate hepatic impairment. The maximum dose of this medicine for patients with moderate hepatic impairment is 5/20/12.5 milligrams once daily. Blood pressure and renal function should be closely monitored in patients with hepatic impairment. This medicine must not be administered to patients with severe hepatic impairment. Elderly patients (65 years of age and older): In general, start treatment at a low dose. When adjusting the dose, consider the patient's renal or cardiac function and comorbidities. Blood pressure should be monitored closely and more frequently in elderly patients. In particular, experience with this medicine in patients 75 years of age and older is very limited, so they should be monitored very carefully when this medicine is administered.
Under 18 years of age: The safety and efficacy of this medicine have not been established in pediatric patients; therefore, its use is not recommended.
This medication should not be used during the second and third trimesters of pregnancy as it can cause serious harm to the fetus and newborn. If pregnancy is confirmed, treatment should be immediately discontinued. Patients with allergies to this medication or its components, or those with certain heart, kidney, or liver conditions, should not take it. This drug should also not be used if blood pressure is too low or in cases of acute heart failure. Patients with low blood volume or low sodium levels should be monitored carefully while taking this medication as hypotension may occur. Patients with compromised kidney function or those who have received a kidney transplant should have regular kidney function tests while taking this medication. Caution is also needed for patients with liver dysfunction or progressing liver cirrhosis. Patients with certain heart valve diseases or obstructive coronary artery diseases should use this drug with caution. Since this medication lowers blood pressure, it can cause dizziness or lightheadedness, so caution is advised when driving or operating machinery. It should be discussed with a doctor if this medication is taken with other antihypertensives, as this may increase blood pressure-lowering effects. The risk of side effects may increase when combined with lithium, certain analgesics, or specific antibiotics. Skin sensitivity to sunlight may occur, so care should be taken regarding sun protection. This medication may cause an electrolyte imbalance in the blood, necessitating regular blood tests, particularly for changes in potassium, sodium, and magnesium levels. If severe diarrhea or vomiting occurs during treatment, there is a risk of dehydration, and immediate consultation with a healthcare provider is advisable. Use of this medication is not recommended while breastfeeding, and breastfeeding should be stopped or medication discontinued if necessary. Safety and effectiveness in children under 18 years have not been established, and use is not recommended. Elderly patients may have impaired kidney or liver function and should start at a lower dose, with careful monitoring of their condition. In the case of overdose, severe hypotension or cardiac side effects may occur, requiring immediate medical attention and appropriate treatment. This medication should be stored out of reach of children, protected from moisture, heat, and direct sunlight.
Peripheral edema, headache, dizziness, upper respiratory tract infection, nasopharyngitis, urinary tract infection, sialadenitis, leukopenia, thrombocytopenia, bone marrow suppression, neutropenia, agranulocytosis, hemolytic anemia, aplastic anemia, anaphylactic reaction, drug hypersensitivity, hyperkalemia, hypokalemia, loss of appetite, diabetes, hypercalcemia, hyperglycemia, hypomagnesemia, hyponatremia, hypochloremia, hypertriglyceridemia, hypercholesterolemia, hyperuricemia, hypochloremic alkalosis, hyperamylasemia, confusion, depression, apathy, sensitivity to stimuli, anxiety, mood changes, sleep disturbances, dizziness, orthostatic dizziness, syncope, taste disorders, hypertension, sensory loss, paresthesia, peripheral neuropathy, drowsiness, fainting, seizures, loss of appetite, tremors, visual disturbances, decreased tearing, worsening of myopia, jaundice, vertigo, tinnitus, palpitations, tachycardia, myocardial infarction, arrhythmia, angina, hypotension, flushing, orthostatic hypotension, vasculitis, thrombosis, embolism, cough, bronchitis, dyspnea, pharyngitis, rhinitis, acute interstitial pneumonia, respiratory distress syndrome, pulmonary edema, diarrhea, nausea, constipation, dry mouth, abdominal pain, changes in bowel habits, abdominal distension, dyspepsia, gastritis, gastric discomfort, gastroenteritis, gingival hyperplasia, paralytic ileus, pancreatitis, vomiting, hepatitis, jaundice, acute cholecystitis, autoimmune hepatitis, hair loss, angioedema, allergic dermatitis, erythema multiforme, erythema, drug-induced lupus erythematosus-like reaction, pustular rash, exfoliative dermatitis, hyperhidrosis, photosensitivity, pruritus, purpura, Quincke's edema, rash, recurrence of lupus erythematosus, toxic skin necrosis, Stevens-Johnson syndrome, urticaria, muscle spasms, joint swelling, muscle weakness, ankle edema, arthralgia, arthritis, low back pain, paresis, myalgia, bone pain, frequent urination, acute renal failure, hematuria, urination disorders, nocturia, interstitial nephritis, renal failure, erectile dysfunction, gynecomastia, asthenia, fatigue, chest pain, fever, influenza-like symptoms, lethargy, boredom, edema, pain, facial edema, elevated serum creatinine, elevated serum urea, elevated serum uric acid, decreased serum potassium, elevated gamma-glutamyl transferase, elevated alanine aminotransferase, elevated aspartate aminotransferase, elevated liver enzymes, elevated serum creatine phosphokinase, weight loss, weight gain, rhabdomyolysis, chronic malabsorption, intestinal vascular edema, altered consciousness, drug hypersensitivity, upper abdominal pain, decreased libido, scrotal edema, asthenia, loss of consciousness, eczema, limb pain, mild decrease in mean hemoglobin and hematocrit levels, dizziness, benign prostatic hyperplasia, benign salivary gland neoplasm, cerebral infarction, renal failure, abdominal bloating, facial flushing, epistaxis, benign prostatic hyperplasia, prostatitis, dysphagia, papular rash, renal cell dysplasia, acute hearing loss, lymphadenitis, acute respiratory distress syndrome, choroidal effusion
Not everyone experiences these, and they can vary from person to person.
This medication may be sensitive to air or moisture, so it should be stored in a tightly sealed container. It is best to maintain the storage temperature between 1 and 30 degrees Celsius at room temperature. Proper storage will help maintain the medication's effectiveness and safety.
Grayish-red round film-coated tablets
28 tablets (14 tablets/PTP x 2)/carton
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Viewing nowCombinationOlmesartan Medoxomil 40mg · Amlodipine Besylate 13.888mg +1 more
Tablet · Prescription medication · Combination
Daicel Corporation (Co., Ltd.)
CombinationOlmesartan Medoxomil 40mg · Amlodipine Besylate 6.944mg +1 more
Tablet · Prescription medication · Combination
Hanmi Daiichi Sankyo Co., Ltd.
CombinationOlmesartan Medoxomil 20mg · Amlodipine Besylate 6.944mg +1 more
Tablet · Prescription medication · Combination
HanKook Daiichi Sankyo Co., Ltd.
Olmesartan Medoxomil · Amlodipine Besylate +1 more
Prescription medication · Combination
SYNEX Co., Ltd.
Olmesartan Medoxomil · Amlodipine Besylate +1 more
Prescription medication · Combination
SYNEX Co., Ltd.
Olmesartan Medoxomil · Amlodipine Besylate +1 more
Prescription medication · Combination
SYNEX Co., Ltd.
CombinationAmlodipine Besylate 6.944mg · Olmesartan Medoxomil 20mg +1 more
Tablet · Prescription medication · Combination
JW Pharmaceutical Corporation
CombinationAmlodipine Besylate 13.888mg · Olmesartan Medoxomil 40mg +1 more
Tablet · Prescription medication · Combination
JW Pharmaceutical Corp.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.